• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600TFX23J
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem Aortic Regurgitation (1716)
Event Date 02/05/2018
Event Type  Injury  
Manufacturer Narrative
Investigation of this event is ongoing.
 
Event Description
As reported by our (b)(4) affiliate, after post-dilation with additional volume the 23mm sapien 3 valve had moderate central leak and a valve-in-valve procedure was performed.At the beginning of the procedure, the right coronary artery was protected due to low height of 7.9mm.A 23mm sapien 3 valve was deployed without problem in a 70:30 aortic/ventricular position.Post-deployment, echo showed mild paravalvular leak (pvl) and post-dilation was performed with an additional 1ml contrast solution added to the nominal volume.After post-dilation, moderate central leak was observed from the right coronary cusp ¿ left coronary cusp.The echo showed a motion abnormality in the leaflets.A new 23mm s3 valve was implanted in the first valve.The procedure was completed after confirming the final pvl was trivial.A guiding catheter had been inserted through the s3 valve's stent for coronary angiography post valve deployment.At that time, the physician felt some resistance.At the end of the procedure, the physician speculated that the valve leaflet might have been damaged while manipulating the guiding catheter post deployment of the first valve.However, it was unclear whether the resistance was a cause of the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
frances preston
1 edwards way
irvine, CA 92614
9492505190
MDR Report Key7312277
MDR Text Key101464819
Report Number2015691-2018-00758
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial
Report Date 02/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/04/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/22/2019
Device Model Number9600TFX23J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/05/2018
Date Device Manufactured10/13/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age83 YR
-
-